Bioceres delivered a net loss of $1.6 million in Q3 2025 on revenues of $60.6 million, down from $84 million a year ago. The decline was mainly due to the absence of the Syngenta downpayment recorded in the prior year. Nevertheless, operating cash flow improved significantly to $23.3 million, supported by better working capital management.
Bioceres Crop Solutions reported total revenues of $106.7 million for the fiscal second quarter ended December 31, 2024, a 24% decline from the previous year, primarily due to challenging market conditions in Argentina affecting crop protection and specialty fertilizers. Despite the revenue decline, the company's gross margin expanded to 42% due to an improved product mix, focusing on higher-margin products. Net income for the quarter was $0.6 million, and Adjusted EBITDA was $15.4 million.